Quantum Biopharma Ltd (QNTM)

NASDAQ

$2.88

$+0.09

(+3.19%)

After-Hours

Quantum Biopharma Ltd (QNTM) Live Price Chart

Last updated: ⁦2026-10-13 20:26:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Quantum Biopharma Ltd (QNTM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $2.88, with a market capitalisation of $23.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.07 to $16.36. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$23.78M
Open	$2.83
Day's High	$38.25
Day's Low	$2.07
Previous Close	$2.82
Volume	82.01K
Average Volume	209.99K
P/E Ratio	--
52-Week High	$16.36
52-Week Low	$2.07
Dividend Yield	--
Earnings Date	--

Quantum Biopharma Ltd (QNTM) After-Hours Stock Price

Quantum Biopharma Ltd (QNTM) is trading at $2.88 in after-hours trading as of 2026-10-13 20:16:00, up 2.13% ($0.06) from the regular-session close of $2.82.

After-hours trading shows how investors are pricing QNTM after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

Quantum Biopharma Ltd (QNTM) 7-Day Stock Price Change

Over the past seven days, Quantum Biopharma Ltd (QNTM) moved from $3.44 to $2.88, representing a decline of 16.28% ($0.56).

The stock traded between $2.80 and $3.49 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 209.85 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

QNTM 52-Week Price Position

Position in Range: 5.7%

52W Low$2.07

52W High$16.36

QNTM is currently trading at $2.88, placing it 5.7% of the way from its 52-week low of $2.07 to its 52-week high of $16.36. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Quantum Biopharma Ltd (QNTM)?

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Quantum Biopharma Ltd Information

Employees	7
Exchange	NASDAQ
Company Website	https://www.quantumbiopharma.com

How to Buy Quantum Biopharma Ltd (QNTM) Stock on MEXC

Eligible investors can buy real shares of Quantum Biopharma Ltd (QNTM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for QNTM and Place Your Order

Open the RealStocks trading page and search for QNTM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Quantum Biopharma Ltd (QNTM) stock price today?

Quantum Biopharma Ltd (QNTM) is currently trading at $ 2.88, up 2.13% ($0.06) from the previous close of $ 2.82. Intraday prices update in real time during regular trading hours.

2.Is QNTM stock going up or down today?

As of 2026-10-13 20:16:00, QNTM is trading at $ 2.88, up 2.13% ($0.06) from its previous close of $ 2.82. The stock has traded between $ 2.07 and $ 38.25 during today’s regular session. Past price movements do not guarantee future results.

3.What is QNTM pre-market price?

As of 2026-10-13 20:16:00, QNTM is trading at $ 2.86 in pre-market trading, up 1.35% ($0.04) from the previous close of $ 2.82. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is QNTM after-hours price?

As of 2026-10-13 20:16:00, QNTM is trading at $ 2.88 in after-hours trading, up 2.13% ($0.06) from the regular-session close of $ 2.82. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is QNTM stock trading now?

QNTM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does QNTM sit relative to its 52-week high and low?

Over the past 52 weeks, QNTM has traded between a low of $ 2.07 and a high of $ 16.36. At $ 2.88, the stock is positioned 5.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Quantum Biopharma Ltd in?

Quantum Biopharma Ltd (QNTM) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Quantum Biopharma Ltd's market capitalisation and where is it listed?

Quantum Biopharma Ltd is listed on the NASDAQ exchange with a market capitalisation of $ 23.78M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is QNTM valued in terms of P/E ratio and EPS?

QNTM trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Quantum Biopharma Ltd pay a dividend?

Quantum Biopharma Ltd pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.